These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy. Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640 [TBL] [Abstract][Full Text] [Related]
10. [Fusion inhibitors. One year therapy with T-20--initial evaluation]. Goebel FD MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046 [No Abstract] [Full Text] [Related]
12. A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide. Beatty G; Hunt P; Smith A; Hoh R; Huang W; Martin J; Deeks SG Antivir Ther; 2006; 11(3):315-9. PubMed ID: 16759047 [TBL] [Abstract][Full Text] [Related]
13. Enfuvirtide (T-20): a novel human immunodeficiency virus type 1 fusion inhibitor. Cervia JS; Smith MA Clin Infect Dis; 2003 Oct; 37(8):1102-6. PubMed ID: 14523775 [TBL] [Abstract][Full Text] [Related]
14. HIV medicine after Barcelona conference: interview with Howard Grossman, M.D. Interview by John S. James. Grossman H AIDS Treat News; 2002 Sep; (383):2-7. PubMed ID: 12765126 [TBL] [Abstract][Full Text] [Related]
15. T-20: 5-drug combination trial for heavily treated NNRTI-naive patients now recruiting. AIDS Treat News; 1999 Jul; (No 323):2-3. PubMed ID: 11366569 [TBL] [Abstract][Full Text] [Related]
16. Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir. Miró O; Garrabou G; López S; Deig E; Vidal I; Infante AB; Cardellach F; Casademont J; Pedrol E Antivir Ther; 2006; 11(5):625-30. PubMed ID: 16964831 [TBL] [Abstract][Full Text] [Related]
17. Adefovir dipivoxil (Preveon) expanded access restrictions being eased. James JS AIDS Treat News; 1998 Feb; (No 288):4-5. PubMed ID: 11365045 [TBL] [Abstract][Full Text] [Related]
18. T-20: entirely new antiretroviral. James JS AIDS Treat News; 1997 Sep; (No 279):5-6. PubMed ID: 11364691 [TBL] [Abstract][Full Text] [Related]
19. FDA panel fails to recommend adefovir approval. Food and Drug Administration. Highleyman L BETA; 1999; 12(4):4. PubMed ID: 11367249 [TBL] [Abstract][Full Text] [Related]